Načítá se...
The Impact of Pancreatic Beta Cell Heterogeneity on Type 1 Diabetes Pathogenesis
PURPOSE OF REVIEW: To discuss advances in our understanding of beta-cell heterogeneity and the ramifications of this for type 1 diabetes (T1D) and its therapy. RECENT FINDINGS: A number of studies have challenged the long-standing dogma that the majority of beta cells are eliminated in T1D. As many...
Uloženo v:
| Vydáno v: | Curr Diab Rep |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Springer US
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6153573/ https://ncbi.nlm.nih.gov/pubmed/30251179 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11892-018-1085-2 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|